Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Chronic Heart Failure

  Free Subscription


01.11.2021

1 Am Heart J
2 Am J Cardiol
3 Cardiol Clin
1 Cardiovasc Res
4 Circ Cardiovasc Qual Outcomes
6 Circ Heart Fail
1 Circulation
9 Eur J Heart Fail
2 Heart
1 Hypertension
1 Int J Cardiol
1 J Am Coll Cardiol
2 J Cardiovasc Pharmacol
1 J Thorac Cardiovasc Surg
1 N Engl J Med
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am Heart J

  1. ARITA VA, Santema BT, De With RR, Nguyen BO, et al
    Atrial function in paroxysmal AF patients with and without heart failure with preserved ejection fraction: data from the AF-RISK study.
    Am Heart J. 2021 Oct 21. pii: S0002-8703(21)00435.
    PubMed         Abstract available


    Am J Cardiol

  2. HARADA T, Obokata M, Omote K, Iwano H, et al
    Functional Tricuspid Regurgitation and Right Atrial Remodeling in Heart Failure With Preserved Ejection Fraction.
    Am J Cardiol. 2021 Oct 23. pii: S0002-9149(21)00945.
    PubMed         Abstract available

  3. PATOULIAS D, Papadopoulos C, Imprialos K, Stavropoulos K, et al
    Meta-Analysis Assessing the Impact of Major Co-Morbidities, Gender, and Race on Cardiovascular Efficacy of Sodium-Glucose Co-Transporter-2 Inhibitors Among Patients With Heart Failure With Preserved or Reduced Ejection Fraction.
    Am J Cardiol. 2021 Oct 20. pii: S0002-9149(21)00949.
    PubMed        


    Cardiol Clin

  4. HATAMIZADEH P
    Cardiorenal Syndrome: An Important Subject in Nephrocardiology.
    Cardiol Clin. 2021;39:455-469.
    PubMed         Abstract available

  5. LAW S, Fontana M, Gillmore JD
    Advances in Diagnosis and Treatment of Cardiac and Renal Amyloidosis.
    Cardiol Clin. 2021;39:389-402.
    PubMed         Abstract available

  6. HATAMIZADEH P
    Introduction to Nephrocardiology.
    Cardiol Clin. 2021;39:295-306.
    PubMed         Abstract available


    Cardiovasc Res

  7. SANTEMA BT, Arita VA, Sama IE, Kloosterman M, et al
    Pathophysiological pathways in patients with heart failure and atrial fibrillation.
    Cardiovasc Res. 2021 Oct 23. pii: 6409189. doi: 10.1093.
    PubMed         Abstract available


    Circ Cardiovasc Qual Outcomes

  8. DAWSON LP, Biswas S, Lefkovits J, Stub D, et al
    Characteristics and Quality of National Cardiac Registries: A Systematic Review.
    Circ Cardiovasc Qual Outcomes. 2021;14:e007963.
    PubMed         Abstract available

  9. OSERAN AS, Wadhera RK
    Promise and Pitfalls of Paying-for-Performance: Learning From the Polish Experience.
    Circ Cardiovasc Qual Outcomes. 2021;14:e008273.
    PubMed        

  10. ATWATER BD, Li Z, Pritchard J, Greiner MA, et al
    Early Increased Physical Activity, Cardiac Rehabilitation, and Survival After Implantable Cardioverter-Defibrillator Implantation.
    Circ Cardiovasc Qual Outcomes. 2021 Jul 21:CIRCOUTCOMES120007580.
    PubMed         Abstract available

  11. SHORE S
    Guiding Sisyphus's Boulder to the Top.
    Circ Cardiovasc Qual Outcomes. 2021;14:e008465.
    PubMed        


    Circ Heart Fail

  12. LI C, Zhao M, Xiao L, Wei H, et al
    Prognostic Value of Elevated Levels of Plasma N-Acetylneuraminic Acid in Patients With Heart Failure.
    Circ Heart Fail. 2021 Oct 29:CIRCHEARTFAILURE121008459.
    PubMed         Abstract available

  13. KHAN MS, Greene SJ, Hellkamp AS, DeVore AD, et al
    Diuretic Changes, Health Care Resource Utilization, and Clinical Outcomes for Heart Failure With Reduced Ejection Fraction: From the Change the Management of Patients With Heart Failure Registry.
    Circ Heart Fail. 2021 Oct 22:CIRCHEARTFAILURE121008351.
    PubMed         Abstract available

  14. MINAMISAWA M, Claggett B, Suzuki K, Hegde SM, et al
    Association of Hyper-Polypharmacy With Clinical Outcomes in Heart Failure With Preserved Ejection Fraction.
    Circ Heart Fail. 2021 Oct 22:CIRCHEARTFAILURE120008293.
    PubMed         Abstract available

  15. NASSIF ME, Spertus JA, Tang F, Windsor SL, et al
    Association Between Change in Ambulatory Hemodynamic Pressures and Symptoms of Heart Failure.
    Circ Heart Fail. 2021 Oct 26:CIRCHEARTFAILURE121008446.
    PubMed        

  16. KOLUPOTI A, Fudim M, Pandey A, Kucharska-Newton A, et al
    Temporal Trends and Prognosis of Physical Examination Findings in Patients With Acute Decompensated Heart Failure: The ARIC Study Community Surveillance.
    Circ Heart Fail. 2021 Oct 27:CIRCHEARTFAILURE121008403.
    PubMed         Abstract available

  17. BALDETTI L, Pagnesi M, Gramegna M, Belletti A, et al
    Intra-Aortic Balloon Pumping in Acute Decompensated Heart Failure With Hypoperfusion: From Pathophysiology to Clinical Practice.
    Circ Heart Fail. 2021 Oct 28:CIRCHEARTFAILURE121008527.
    PubMed         Abstract available


    Circulation

  18. YAZAKI Y, Nakamura M, Iijima R, Yasuda S, et al
    Clinical Outcomes of Rivaroxaban Monotherapy in Heart Failure Patients With Atrial Fibrillation and Stable Coronary Disease: Insights From the AFIRE Trial.
    Circulation. 2021;144:1449-1451.
    PubMed        


    Eur J Heart Fail

  19. WEI D, Li J, Janszky I, Chen H, et al
    Death of a child and the risk of heart failure: a population-based cohort study from Denmark and Sweden.
    Eur J Heart Fail. 2021 Oct 24. doi: 10.1002/ejhf.2372.
    PubMed         Abstract available

  20. TOMASONI D, Adamo M, Metra M
    September 2021 at a glance: focus on biomarkers, sex differences and adherence to medical treatment.
    Eur J Heart Fail. 2021;23:1419-1421.
    PubMed        

  21. BLUMER V, Gayowsky A, Xie F, Greene SJ, et al
    Effect of patient-centered transitional care services on patient-reported outcomes in heart failure: sex-specific analysis of the PACT-HF randomized controlled trial.
    Eur J Heart Fail. 2021;23:1488-1498.
    PubMed         Abstract available

  22. TOPS LF, Coats AJS, Ben Gal T
    The ever-changing field of mechanical circulatory support: new challenges at the advent of the 'single device era'.
    Eur J Heart Fail. 2021;23:1428-1431.
    PubMed        

  23. AIMO A, Saccaro LF, Borrelli C, Fabiani I, et al
    The ergoreflex: how the skeletal muscle modulates ventilation and cardiovascular function in health and disease.
    Eur J Heart Fail. 2021;23:1458-1467.
    PubMed         Abstract available

  24. YUZEFPOLSKAYA M, Colombo PC
    Reply to 'Existing evidence supports clinical trials on interventions preventing ventricular assist device infection in patients colonized with Staphylococcus aureus'.
    Eur J Heart Fail. 2021;23:1566-1567.
    PubMed        

  25. NURJADI D, Ruhparwar A, Zanger P
    Existing evidence supports clinical trials on interventions preventing ventricular assist device infection in patients colonized with Staphylococcus aureus. Letter regarding the article 'Association of preoperative infections, nasal Staphylococcus aur
    Eur J Heart Fail. 2021;23:1566.
    PubMed        

  26. FERREIRA JP, Konstam MA, McMurray JJV, Butler J, et al
    Dosing of losartan in men versus women with heart failure with reduced ejection fraction: the HEAAL trial.
    Eur J Heart Fail. 2021;23:1477-1484.
    PubMed         Abstract available

  27. FRASER AG, Szymanski P
    Heart valve disease, left ventricular hypertrophy, and heart failure: a lifelong relationship and continuing clinical responsibility.
    Eur J Heart Fail. 2021 Oct 24. doi: 10.1002/ejhf.2373.
    PubMed        


    Heart


  28. Correction: Sodium-glucose co-transporter 2 inhibitor therapy: mechanisms of action in heart failure.
    Heart. 2021;107:e15.
    PubMed        

  29. CHAN DZL, Kerr A, Grey C, Selak V, et al
    Contrasting trends in heart failure incidence in younger and older New Zealanders, 2006-2018.
    Heart. 2021 Oct 22. pii: heartjnl-2021-319853. doi: 10.1136/heartjnl-2021-319853
    PubMed         Abstract available


    Hypertension

  30. KULKARNI S, Dominiczak AF, Touyz RM, Spence JD, et al
    CONNed in Pregnancy.
    Hypertension. 2021;78:241-249.
    PubMed        


    Int J Cardiol

  31. AHMED S, Ahmed A, Radegran G
    Plasma tumour and metabolism related biomarkers AMBP, LPL and Glyoxalase I differentiate heart failure with preserved ejection fraction with pulmonary hypertension from pulmonary arterial hypertension.
    Int J Cardiol. 2021 Oct 25. pii: S0167-5273(21)01690.
    PubMed         Abstract available


    J Am Coll Cardiol

  32. KLEINER SHOCHAT M, Fudim M, Kapustin D, Kazatsker M, et al
    Early Impedance-Guided Intervention Improves Long-Term Outcome in Patients With Heart Failure.
    J Am Coll Cardiol. 2021;78:1751-1752.
    PubMed        


    J Cardiovasc Pharmacol

  33. YANG Y, Shen C, Lu J, Fu G, et al
    Sacubitril/valsartan in the treatment of right ventricular dysfunction in patients with heart failure with reduced ejection fraction: a real-world study.
    J Cardiovasc Pharmacol. 2021 Oct 21. pii: 00005344-900000000-98124.
    PubMed         Abstract available

  34. MASARONE D, Melillo E, Errigo V, Martucci ML, et al
    Haemodynamic Effects of Levosimendan in Outpatients with Advanced Heart Failure: An Echocardiographic Pilot Study.
    J Cardiovasc Pharmacol. 2021 Oct 23. pii: 00005344-900000000-98126.
    PubMed         Abstract available


    J Thorac Cardiovasc Surg

  35. LI S, Zimpfer D, Mahr C
    Commentary: Transcending acceptable, moving toward optimal: Standardizing surgical configurations of ventricular assist device therapy.
    J Thorac Cardiovasc Surg. 2021;162:1566-1567.
    PubMed        


    N Engl J Med

  36. FRUSH BW
    Cool Water.
    N Engl J Med. 2021;385:1254-1255.
    PubMed        


    PLoS One

  37. LV S, Ru S
    The prevalence of malnutrition and its effects on the all-cause mortality among patients with heart failure: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0259300.
    PubMed         Abstract available

  38. JONSSON HOLMDAHL A, Norberg H, Valham F, Bergdahl E, et al
    Mineralocorticoid receptor antagonists use in patients with heart failure and impaired renal function.
    PLoS One. 2021;16:e0258949.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: